16-11548386-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001136472.2(LITAF):​c.*1251A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.378 in 453,582 control chromosomes in the GnomAD database, including 32,870 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 10708 hom., cov: 31)
Exomes 𝑓: 0.38 ( 22162 hom. )

Consequence

LITAF
NM_001136472.2 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.40

Publications

24 publications found
Variant links:
Genes affected
LITAF (HGNC:16841): (lipopolysaccharide induced TNF factor) Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]
LITAF Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 1C
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • Charcot-Marie-Tooth disease
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 16-11548386-T-C is Benign according to our data. Variant chr16-11548386-T-C is described in ClinVar as [Benign]. Clinvar id is 317757.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.503 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LITAFNM_001136472.2 linkc.*1251A>G 3_prime_UTR_variant Exon 4 of 4 ENST00000622633.5 NP_001129944.1 Q99732-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LITAFENST00000622633.5 linkc.*1251A>G 3_prime_UTR_variant Exon 4 of 4 1 NM_001136472.2 ENSP00000483114.1 Q99732-1
LITAFENST00000339430.9 linkc.*1251A>G 3_prime_UTR_variant Exon 4 of 4 1 ENSP00000340118.5 Q99732-1
LITAFENST00000571688.6 linkc.*1251A>G 3_prime_UTR_variant Exon 4 of 4 1 ENSP00000459533.1 Q99732-1
LITAFENST00000413364.6 linkc.*1376A>G 3_prime_UTR_variant Exon 5 of 5 2 ENSP00000397958.2 Q99732-3

Frequencies

GnomAD3 genomes
AF:
0.372
AC:
56458
AN:
151692
Hom.:
10693
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.390
Gnomad AMI
AF:
0.249
Gnomad AMR
AF:
0.331
Gnomad ASJ
AF:
0.395
Gnomad EAS
AF:
0.519
Gnomad SAS
AF:
0.424
Gnomad FIN
AF:
0.327
Gnomad MID
AF:
0.385
Gnomad NFE
AF:
0.364
Gnomad OTH
AF:
0.355
GnomAD2 exomes
AF:
0.388
AC:
50577
AN:
130444
AF XY:
0.391
show subpopulations
Gnomad AFR exome
AF:
0.399
Gnomad AMR exome
AF:
0.358
Gnomad ASJ exome
AF:
0.407
Gnomad EAS exome
AF:
0.535
Gnomad FIN exome
AF:
0.338
Gnomad NFE exome
AF:
0.362
Gnomad OTH exome
AF:
0.370
GnomAD4 exome
AF:
0.381
AC:
114843
AN:
301770
Hom.:
22162
Cov.:
0
AF XY:
0.386
AC XY:
66371
AN XY:
171986
show subpopulations
African (AFR)
AF:
0.398
AC:
3406
AN:
8554
American (AMR)
AF:
0.358
AC:
9768
AN:
27272
Ashkenazi Jewish (ASJ)
AF:
0.409
AC:
4408
AN:
10786
East Asian (EAS)
AF:
0.533
AC:
4912
AN:
9210
South Asian (SAS)
AF:
0.418
AC:
24911
AN:
59646
European-Finnish (FIN)
AF:
0.339
AC:
4189
AN:
12364
Middle Eastern (MID)
AF:
0.374
AC:
430
AN:
1150
European-Non Finnish (NFE)
AF:
0.363
AC:
57581
AN:
158750
Other (OTH)
AF:
0.373
AC:
5238
AN:
14038
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
4462
8925
13387
17850
22312
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
400
800
1200
1600
2000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.372
AC:
56518
AN:
151812
Hom.:
10708
Cov.:
31
AF XY:
0.373
AC XY:
27638
AN XY:
74166
show subpopulations
African (AFR)
AF:
0.390
AC:
16135
AN:
41380
American (AMR)
AF:
0.331
AC:
5046
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.395
AC:
1371
AN:
3468
East Asian (EAS)
AF:
0.520
AC:
2680
AN:
5156
South Asian (SAS)
AF:
0.425
AC:
2040
AN:
4804
European-Finnish (FIN)
AF:
0.327
AC:
3437
AN:
10524
Middle Eastern (MID)
AF:
0.380
AC:
111
AN:
292
European-Non Finnish (NFE)
AF:
0.364
AC:
24706
AN:
67930
Other (OTH)
AF:
0.362
AC:
765
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1764
3529
5293
7058
8822
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
558
1116
1674
2232
2790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.365
Hom.:
13678
Bravo
AF:
0.375
Asia WGS
AF:
0.496
AC:
1726
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease type 1C Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.44
DANN
Benign
0.43
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7102; hg19: chr16-11642242; API